4th Global Congress on Sickle Cell Disease
Join Biomaneo & Shimadzu at the 4th Global Congress on Sickle Cell Disease taking place in Paris from June 16-18.
Biomaneo obtains ISO 13485:2016 certification and strengthens its quality team
A key step for the marketing of its In Vitro Diagnostic Devices (IVDD) and in the transition to the new 2017/746 regulation.
New NeoSickle installation
With this second installation, 80% of French samples are now analysed using the NeoSickle solution.
Biomaneo puts the spotlight on the training of young people...
By welcoming three new employees to its teams
Biomaneo obtains the "Label Initiative Remarquable"
We are pleased to announce that we have just joined the 1st community of impact entrepreneurs in France...